Retina

Direct visualization delivery of bevacizumab in pseudophakic eyes for the treatment of subretinal neovascularization

The path to truly effective AMD therapies is long and requires us to recognize that it’s not a single disease entity: toil and teamwork are needed to triumph

Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.

Five Things We Learned This Month

Sitting Down With… Joan Miller, Chief and Chair of the Department of Ophthalmology, Massachusetts Eye and Ear, Mass General Hospital and Harvard Medical School

“Smart” nanowires deliver drugs on demand using an applied electromagnetic field

Stem cell therapies may be the future of treating retinal disease, but how do you choose the best source?

The Argus II: Thirty Patients with RP, Three Years Later

Five Things We Learned This Month

A protein involved in autophagy, DRAM2, appears to be essential for photoreceptor survival